Twitter Beğeni Hilesi

📣Peter Visscher PCTG is recruiting a (senior) postdoctoral researcher to join his group in Oxford Big Data Institute. If I was 15 years younger I'd be throwing my hat in the ring! my.corehr.com/pls/uoxrecruit…

All set for #PrevConf24!

Happy to share the first paper from my lab out today in #NeuroOncology, an examination of polygenic risk scores (#PRS) for glioma subtypes, led by future MD Taishi Nakase 🧠🧬 academic.oup.com/neuro-oncology… Stanford Medicine Stanford Cancer Institute Stanford Epidemiology & Population Health

📝 New publication: Identifying #proteomic risk factors for overall, aggressive, and early onset #prostatecancer using Mendelian Randomisation and tumour spatial transcriptomics. Read now 👉 bit.ly/3XC0i4H Cancer Research UK Karl Smith-Byrne (he/him) Josh Atkins Alastair Lamb

Congratulations Trishna and team

Well done Zhe .. representing the CEU in Boston Oxford Population Health (OxPop) .. has been an inspiring conference thanks Science and Innovation at Cancer Research UK

You come to UK, highly educated, fully trained, to use your unique talent to further science and how is the government welcoming you? By asking you to pay thousands of £££ for the privilege. What an atrocity. theguardian.com/education/arti…

I'm delighted that our GeneBayes paper reporting highly accurate and interpretable estimates of gene constraint (against LOF mutations) is out now! GeneBayes builds on pioneering work on pLI + LOEUF from groups at Broad, and work on s_het + hs from Sunyaev and Przeworski labs.

Can proteomics complement disease risk prediciton❓ 👉New data from the UKB-PPP project (N=41,931) suggest it could. 📊Adding 5 to 20 proteins to clinical data/assays led to improved 10-year prediction models for 67 pathologically diverse diseases 🔗nature.com/articles/s4159…

Proteins, proteins, proteins. How 3,000 blood proteins can help predict 10-year risk of >200 common and rare diseases, beyond genomic markers nature.com/articles/s4159… UK Biobank Nature Medicine

Multicancer Early Detection Tests — Keeping a High Bar for Evidence of Benefit | New England Journal of Medicine, by Hilary Robbins nejm.org/doi/10.1056/NE…

New GWAS data for 464 phenotypes from 4,145 individuals in Biobank Russia🧬 nature.com/articles/s4146… Summary stats 📊 available for download here: 🔗biobank.almazovcentre.ru

Niceee

Excited to share our HLA-pQTL study revealing widespread HLA trans effects on protein expression in UK Biobank- now out at Nature Communications with Xinli Hu, Josh Chiou, Soumya Raychaudhuri সৌম্য রায়চৌধুরী, Saori Sakaue, Joyce Kang, PhD, and many more Pfizer Inc.! nature.com/articles/s4146…

Does anyone have a working solution to deal with these types of emails ?? or better -> Does anyone have a tool to reverse spam them to waste their time ?

Genome-wide copy number association study of Parkinson's disease in ~11k (2.7k early onset) and ~9k controls identifies 13 duplications and one deletion. Among the genes hit by the CNVs are some known PD genes like SNCA and PRKN. But also many novel ones, including genes linked

Its great seeing how much the city i was born and raised in has progressed mostly thanks to this wonderful human. Make sure you vote Nuatali Nelmes so she can keep doing a fabulous job here in #Newcastle

Great write up of the amazing work that Zhe is leading Science and Innovation at Cancer Research UK Oxford Population Health (OxPop)

Very excited to share our (Dr William Reay , Murray Cairns) latest study which explored epigenetic heterogeneity in schizophrenia. nature.com/articles/s4138…